Google News – Clinical Trials External News
Regulatory & Compliance Articles
Google News – Biopharma External News
GC Biopharma wins approval for phase 2 Covid-19 mRNA vaccine trial - Korea Biomedical Review
Google News – Biopharma External News
FDA partially halts trials of SK Biopharmaceuticals’ epilepsy drug candidate - Korea JoongAng Daily
Google News – Medical Devices External News
Nutromics receives FDA Breakthrough Device Designation - Business Wire
Google News – FDA (biotech/pharma) External News
SK biopharmaceuticals says $400 mil. opakalim payment awaits FDA hold resolution - Korea Biomedical Review
Google News – FDA (biotech/pharma) External News
Friday Five – Novartis' stumbles spark boardroom backlash, Nodthera name drops, FDA throws wrench into Biohaven deal…and more - FirstWord Pharma
Google News – Clinical Trials External News
FDA Clears CU Anschutz Clinical Trial Using Engineered Immune Cells to Fight Colorectal Cancer - PR Newswire
Google News – FDA (biotech/pharma) External News
FDA expands indication for Bayer’s Hyrnuo - The Pharma Letter
Google News – Clinical Trials External News
Strengthening female participation in clinical trials with AI-driven eConsent - europeanpharmaceuticalreview.com
Google News – FDA (biotech/pharma) External News
Recon: UK unveils recommendations for regulating AI in medicine; FDA halts new enrollment in Biohaven epilepsy trials - RAPS
Industry News External News
Arkansas Advance Healthcare Directives Remain Valid Under Guardianship and State Hospital Admission - KVOM 101.7
Google News – Pharmaceuticals External News
Jacksonville protest demands city council divest from TEVA Pharmaceuticals and Israeli bonds - Fight Back! News
Google News – Biopharma External News
FDA places partial hold on Biohaven’s epilepsy drug - biopharmadive.com
Google News – Pharmaceuticals External News
Olema Pharmaceuticals (NASDAQ:OLMA) Shares Up 3.5% - Should You Buy? - MarketBeat
Google News – Medical Devices External News